Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

518 public trials 102 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck

NCT00513383

Conditions: Carcinoma, Carcinoma, Adenosquamous, Carcinoma, Squamous Cell, +8 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

EPO906 in Carcinoid and Other Neuroendocrine Tumors

NCT00050349

Conditions: Adenocarcinoma, Carcinoid, Carcinoid Tumor, +23 more
Locations: Northwestern University Chicago, Illinois, United States

University of Iowa Health Care Iowa City, Iowa, United States

LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Deptof LSU Health Sciences (2) New Orleans, Louisiana, United States

Weill Medical College of Cornell Univ. New York, United States

View Trial Details

Completed

A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients

NCT01576380

Conditions: Adenocarcinoma, Adenocarcinoma, Scirrhous, Carcinoma, +16 more
Locations: Novartis Investigative Site Nagoya, Aichi-ken, Japan

Novartis Investigative Site Kashiwa, Chiba, Japan

Novartis Investigative Site Matsuyama, Ehime, Japan

Novartis Investigative Site Sapporo, Hokkaido, Japan

View Trial Details

Completed

EPO906 Therapy in Patients With Prostate Cancer

NCT00035113

Conditions: Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
Locations: Pacific Shores Medical Group Long Beach, California, United States

California Pacific Medical Center San Francisco, California, United States

University of Maryland - Greenbaum Cancer Center Baltimore, Maryland, United States

Cancer Institute of New Jersey (CINJ) New Brunswick, New Jersey, United States

View Trial Details

Completed

Tecemotide (L-BLP25) in Rectal Cancer

NCT01507103

Conditions: Carcinoma, Colorectal Neoplasms, Digestive System Diseases, +12 more
Locations: NKI (Nederlands Kanker Instituut) Amsterdam, Netherlands

View Trial Details

Completed

Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.

NCT01043523

Conditions: Abdominal Abscess, Abscess, Adenocarcinoma, +14 more
Locations: Palo Alto, California, United States

New York, United States

Durham, North Carolina, United States

Cinncinati, Ohio, United States

View Trial Details

Completed

Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.

NCT01035229

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States

Compassionate Cancer Care Medical Group CCCMG Fountain Valley, California, United States

University of California San Diego - Moores Cancer Center SC - 3 La Jolla, California, United States

California Pacific Medical Center California Pacific Med San Francisco, California, United States

View all 131 locations

View Trial Details

Completed

Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer

NCT01352884

Conditions: Cancer, Carcinoma, Melanoma, +16 more
Locations: Karmanos Cancer Institute Detroit, Michigan, United States

Memorial Sloan Kettering Cancer Center New York, United States

Carolina BioOncology Institute Huntersville, North Carolina, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

View Trial Details

Completed

RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe

NCT00688753

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: Novartis Investigative Site Brussels, Belgium

Novartis Investigative Site Ghent, Belgium

Novartis Investigative Site Bordeaux, France

Novartis Investigative Site Lyon, France

View all 19 locations

View Trial Details

Completed

ZD6474(Vandetanib) + Alimta Combo Study

NCT00506051

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more
Locations: Not specified

View Trial Details